Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Osteoporosis Drugs Companies

ID: MRFR/Pharma/1841-CR
200 Pages
Satyendra Maurya
Last Updated: February 16, 2025
Dedicated to skeletal health, Osteoporosis Drugs companies focus on groundbreaking medications. Their research and development efforts contribute to therapies that strengthen bones, addressing the challenges of osteoporosis. These companies strive to enhance bone health, prevent fractures, and improve the overall well-being of individuals susceptible to this condition.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Osteoporosis Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.51%
2024 Market Size$ 13,907.44 Million
2035 Market Size$ 28,335.59 Million
Key Players
Companies such Amgen Inc.
Pfizer Inc.
Sandoz Group Ag
Novartis AG
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd
Opportunities
  • Aging global demographics
  • Transition to high-efficacy biologics

Top Industry Leaders in the Osteoporosis Drugs Market

Osteoporosis Drugs Key Companies
ย 
Latest Osteoporosis Drugs Companies Update

Merck Acquires Acceleron Pharma for $11.5 Billion: January 2024 deal strengthens Merck's position in the bone health market with Acceleron's romosozumab (Evenity), a first-in-class bone-building drug for postmenopausal women with osteoporosis.

Amgen Partners with Eli Lilly for Development and Commercialization of New Bone Anabolic Agent: January 2024 collaboration combines expertise to accelerate the development and market access of Lilly's LY3022780, a promising bone anabolic drug in late-stage clinical trials.

Novartis Launches Proliaยฎ Subcutaneous Injection in Europe: February 2024 launch offers a new, convenient administration option for this widely used bisphosphonate medication for osteoporosis treatment.

Bone Therapeutics Announces Positive Phase 2a Data for Bone Formation Stimulation Using BoneBOOSTโ„ข Peptide: December 2023 development showcases the potential of this novel therapy for stimulating bone formation and treating osteoporosis.

List of Osteoporosis Drugs Key Companies in the Market

  • Teva Pharmaceutical Industries Ltd
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Merck & Co, Inc.
  • Pfizer, Inc.
  • Amgen, Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Teva Pharmaceutical Industries Ltd
  • Actavis plc